Dimensional Fund Advisors’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Dimensional Fund Advisors’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-22,979	Closed	-$241K	–	3313
2016 Q1	$241K	Hold	22,979	–	–	﹤0.01%	3156
2015 Q4	$678K	Buy	22,979 +172	+0.8%	+$5.2K	﹤0.01%	3035
2015 Q3	$721K	Sell	22,807 -371	-2%	-$17.7K	﹤0.01%	3058
2015 Q2	$1.37M	Buy	23,178 +1,943	+9%	+$137K	﹤0.01%	2945
2015 Q1	$2.27M	Sell	21,235 -647	-3%	-$61.7K	﹤0.01%	2792
2014 Q4	$2.06M	Hold	21,882	–	–	﹤0.01%	2835
2014 Q3	$1.68M	Buy	21,882 +698	+3%	+$55K	﹤0.01%	2884
2014 Q2	$1.9M	Buy	21,184 +9,525	+82%	+$584K	﹤0.01%	2871
2014 Q1	$624K	Hold	11,659	–	–	﹤0.01%	3145
2013 Q4	$294K	Buy	11,659 +418	+4%	+$9.96K	﹤0.01%	3243
2013 Q3	$307K	Sell	11,241 -7	-0.1%	-$225	﹤0.01%	3258
2013 Q2	$406K	Buy	+11,248	New	+$422K	﹤0.01%	3217

Other funds holding PTX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Dimensional Fund Advisors's PTX Position: Q2 2016 in Review

Dimensional Fund Advisors sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2016, closing a stake of 22,979 shares — an estimated $241K sold.

Dimensional Fund Advisors first reported a position in PTX in Q2 2013 and held it in 12 quarters. The position peaked at $2.27M in Q1 2015. 56 funds tracked by Wall St. Rank hold PTX as of Q2 2016.

Dimensional Fund Advisors reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2016 after selling out during the quarter.
Dimensional Fund Advisors sold 22,979 Pernix Therapeutics Holdings, Inc. shares in Q2 2016, an estimated $241K.
Dimensional Fund Advisors first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2013 and held it in 12 quarters.
Dimensional Fund Advisors's Pernix Therapeutics Holdings, Inc. position peaked at $2.27M in Q1 2015.
56 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2016.

Based on Dimensional Fund Advisors's 13F filing for Q2 2016, filed 9 Aug 2016.